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SUMMARY
The authors report the use of synthetic beta-tricalcium phosphate 
with type I collagen immediately after tooth extraction for simple socket 
preservation indicated in the pre-implant management of alveolar bone. 
The bone material was used without a barrier membrane and forming 
a mucoperiosteal flap. Clinical examination revealed solid new bone 
formation with no changes in vertical and horizontal dimensions 9 months 
after the socket preservation. Immunohistochemical analysis demonstrated 
presence of active osteonectine-positive cells. The new bone formed after 
the use of beta-tricalcium phosphate and type I collagen in the socket 
preservation method can allow dental implant placement and implant 
loading.
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Dental implants have become generally accepted 
treatment in the management of partially or totally 
edentulous patients. For successful clinical outcomes, 
adequate quality and quantity of bone are necessary to 
ensure long-term implant stability. However, significant 
reduction in bone volume in both horizontal and vertical 
directions after tooth extraction may affect the successful 
placement and osseointegration of dental implants1,2.
The preservation of the socket dimensions 
immediately after tooth extraction is a method which 
has been attempted by different bone substitutes to 
increase the quality of bone regeneration and to maintain 
the original dimensions of alveolar bone3-5. Beta-
tricalcium phosphate (β-TCP) is synthetic material with 
osteoconductive properties. Bone regeneration with 
successful clinical and histological results has been 
reported in cases where β-TCP was used to fill bone 
defects after cyst removal, sinus-lift surgery and isolated 
alveolar ridge augmentation without the use of a barrier 
membrane6-8. 
The aim of this report was to present clinical, 
radiographic and immunihistochemical evidence of the 
extraction socket preservation in a patient treated with 
β-TCP associated with type I collagen prior to dental 
implant placement.
Case Report
A 30-year-old healthy female was presented for 
implant placement consultation after the extraction of 
second upper left premolar for single-crown rehabilitation. 
The tooth was indicated to be removed since the 
transversal fracture of the root was found with the failure 
of endodontic treatment (Fig. 1a). 
The tooth extraction was done under the maxillary 
infiltration anaesthesia. After extraction of the tooth and 
wound debridement, the extraction socket was filled with 
beta-tricalcium phosphate and type I collagen (β-TCP/
Clg - RTR Cone®, Septodont, Saint-Maur-des-Fosses, 
France) from the apical part of the socket to the crestal 
bone level. The material and the socket opening were left 
to heal spontaneously since no barrier membrane was 
used for the guided tissue regeneration, or mucoperiosteal 
flap performed (Fig. 1b). A course of antibiotics and 
pain medication with appropriate instructions were 
administered to the patient for 5 days. The follow-up 
examinations were done at 3, 5 and 7 days, and, associated 
with radiographs, at 4 and 9 months after the placement of 
the material. 
Figure 1a. Radiograph confirms indication for tooth extraction
Figure 2a. 3 days after β-TCP/Clg placement and subsequent closure of 
the socket opening;
Figure 1b. β-TCP/Clg placed into the alveolar socket and secured by 
sutures. No barrier membrane and mucoperiosteal flap used
Figure 2b. A complete closure of socket opening after 2 weeks;
Nine months after the socket preservation, the re-entry 
procedure of the grafted area was done for bone biopsy and 
implant placement (Replace®, NobelBiocare, Sweden). 
The bone was evaluated by immunohistochemical analysis 
using 4 μm thick sections, mounted on poly-L-lysine 
coated glass slides. Antigen retrieval was achieved by 
heating slides with citrate buffered solution into a micro-
wave oven at 2 circles of 5 min each. Afterwards, sections 
were incubated in 4 C° in a humified chamber with the 
primary antibody against osteonectin (clone NCL-O-
NECTIN 15G12, Novocastra Co.UK) at a dilution 1:20 
overnight. A 2-step technique was used for the secondary 
antibody (Envision, Dako Ca, USA). Diaminobenzidine 
was preferred as chromogen and slides were lightly 
counterstained with haematoxylin and mounted. 
Clinically, the grafted area healed uneventfully with 
completed gingiva closure of the socket opening in 2 
weeks (Fig. 2, a and b). There were no signs of infection, 
exudation or material loosing during the observation 
period of 9 months. The residual alveolar bone 9 months 
after the socket preservation was adequate for the 
implant placement (length of 12 mm, and diameter of 4.3 
mm), without significant resorption in both vertical and 
horizontal directions (Fig. 2, c-e). There were no clinical 
signs and symptoms of implant/crown failure 2 years after 
loading (Fig. 2f).
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Figure 2c. Healed gingival wound 9 months after alveolar socket 
preservation;
Figure 3a. Periapical radiograph taken 7 days after the placement of 
β-TCP/Clg;
Figure 2d. Re-entry of the alveolar bone for implant insertion 9 months 
after alveolar socket preservation. New bone formation is compact and 
solid without horizontal resorption of alveolar ridge;
Figure 3b. Radiograph taken after 6 months showing peripheral bone 
formation and central radiolucency; 
Figure 2e. No reduction in vertical dimension of the alveolar ridge 9 
months after the socket preservation
Figure 2f. Radiograph of the implant and crown 2 years after the 
prosthetic rehabilitation
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Radiographically, a radio-dense structure of bone 
appeared to be seen peripherally, with central location 
of radio-lucency after 9 months of healing period (Fig. 
3, a-c). There was no appearance of the residual graft 
material at the time of implant placement. Two years of 
loading did not show a crestal bone resorption around the 
implant body (Fig. 2f).
Immunohistochemically, the osteonectine expres-
sion was mainly detected in differentiating osteoblasts 
or osteoblast-like cells lying over the newly formed 
bone (Fig. 4a). Some osteonectine positive cells were 
also found in bone marrow (Fig. 4b). The intensity 
of positive immunostaining was graded from mild to 
strong. 
Discussion
This case demonstrates that β-TCP/Clg provides an 
effective scaffold which can allow in-growth of active 
cellular and vascular components inside the material. 
This characteristic of osseoconductive material will 
promote a formation of new mineralized bone and bone 
marrow in a human extraction socket. The presence of 
newly formed bone, lined with osteonectine-positive 
cells, demonstrated that active bone formation was still 
in process. Furthermore, osteonectine-staining cells were 
taking places not only around new bone but also inside of 
fibrous tissue, which finally resulted in the appearance of 
new centres of ossification. In addition, type I collagen 
combined with β-TCP induces osteogenesis by supporting 
osteoblastic differentiation and proliferation resulted in 
acceleration of the healing process in bone defects9,10. 
There was no residual graft material detected after 
9 months because the relatively fast biodegradation 
of β-TCP occurs by both chemical dissolution and 
osteoclastic-cell activity11 what could be a reason why the 
slight central radiolucency were observed on radiographs. 
The most important factor seams to be that a barrier 
membrane and a mucoperiosteal flap have not played any 
crucial rule in case with all 4-wall socket preservation 
what was also documented by Herberer et al12 using 
BioOss + Collagen in the same model of human socket 
preservation. The alveolar crestal bone level did not 
change over time of bone healing, as well as during the 
loading time of 2 years. On the other hand, resorption 
of the alveolar bone during the physiological healing of 
extraction sockets is usually expected with the significant 
changes in the first 3 months after extraction1. There are 
several possible mechanisms to explain the blockade of 
fibrous tissue in-growth into the porous material structure 
of the β-TCP granules. Metabolites and a local decrease 
in pH during the material dissolution can inhibit the 
fibroblastic proliferation13,14, while afterward that process 
will be intensive by a strong connection of material and 
bone through the ions reaction9,15. 
Figure 4a. Osteonectine-stained β-TCP/Clg-treated socket 9 months 
after alveolar socket  preservation. Cells stained for osteonectine 
were seen close to the mineralized new bone formation (an original 
magnification x 100);
Figure 4b. Osteonectine-positive cells localized in fibrous tissue and 
bone marrow (an original magnification x 100)
Figure 3c. Radiograph taken after 9 months showing complete bone fill 
of the socket with slight decrease in bone density at the central position
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Regarding the results of this clinical case, it can be 
concluded that the combination of β-TCP/Clg can prevent 
the reduction of original dimension of the alveolar bone 
when used for the preservation of 4-wall extraction socket 
without the barrier membrane and surgical flap used. The 
active bone formation ensured the quality of regeneration 
important for successful implant osseointegration.
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